Literature DB >> 2558700

Altered adrenoceptor responsiveness during adrenaline infusion but not during mental stress: differences between receptor subtypes and tissues.

P T Larsson1, A Martinsson, G Olsson, P Hjemdahl.   

Abstract

1. Effects of 3 h infusions of adrenaline (0.4 nmol kg-1 min-1) or placebo and of mental stress evoked by a colour word test (CWT) on adrenergic receptor function were investigated in healthy men. Responses of heart rate, blood pressure, plasma catecholamines, plasma cyclic AMP and plasma free fatty acids (FFA) were evaluated during infusions and CWT. In vitro beta 2-adrenoceptor numbers [( 125I]-HYP binding) and function (isoprenaline induced cyclic AMP accumulation) were studied on lymphocytes in all experiments. alpha 2-adrenoceptor binding [( 3H]-yohimbine and adrenaline) to intact platelets was evaluated in the infusion experiments only. 2. Placebo infusion evoked no major alterations of any parameter. 3. Adrenaline infusion raised venous plasma adrenaline levels to 4-5 nmol l-1, increased heart rate by 14 +/- 3 beats min-1 and plasma cyclic AMP by 17 +/- 3 nmol l-1, and decreased diastolic blood pressure by 15 +/- 5 mm Hg. These responses persisted throughout the infusion. Plasma FFA levels, on the other hand, increased at 30 min of infusion (from 236 +/- 44 to 717 +/- 92 mumol l-1) and returned to basal levels after 3 h of infusion. 4. In vitro, lymphocytes showed increased beta 2-responsiveness after 30 min of adrenaline infusion (delta cyclic AMP increased from 1.86 +/- 0.24 to 3.06 +/- 0.58 pmol/10(6) cells), but a decreased response (0.47 +/- 0.10 pmol/10(6) cells) after 3 h of infusion. [125I]-HYP binding to lymphocyte membranes showed a three-fold increase of Bmax at 30 min of adrenaline infusion followed by a return to basal values after 3 h of infusion. [125I]-HYP binding reflected the functional responsiveness of the lymphocytes in vitro poorly. alpha 2-adrenoceptors on platelets were not altered with regard to Bmax or Kd for [3H]-yohimbine binding or Ki for adrenaline displacement of [3H]-yohimbine binding. 5. CWT evoked marked circulatory changes, a four-fold increase in plasma adrenaline and a 60% increase in beta 2-adrenoceptor binding sites without changes in functional responsiveness of the lymphocytes. 6. We conclude that exposure to high physiological levels of adrenaline in vivo alters lymphocyte beta-adrenoceptor responsiveness in a biphasic manner, with an early increase followed by a later decrease, but that most beta-adrenoceptor mediated responses to adrenaline in vivo remain intact. Lymphocyte alterations may reflect recruitment of cells into the circulation during sympathoadrenal stimulation. Platelet alpha 2-adrenoceptors are apparently not easily subjected to agonist induced dynamic receptor regulation.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2558700      PMCID: PMC1380037          DOI: 10.1111/j.1365-2125.1989.tb03559.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  35 in total

1.  Haemodynamic effects of adrenaline during treatment of hypertensive patients with propranolol and metoprolol.

Authors:  C L van Herwaarden; J F Fennis; R A Binkhorst; A van't Laar
Journal:  Eur J Clin Pharmacol       Date:  1977-12-28       Impact factor: 2.953

2.  Saturation assay for cyclic AMP using endogenous binding protein.

Authors:  B L Brown; R P Ekins; J D Albano
Journal:  Adv Cyclic Nucleotide Res       Date:  1972

3.  Catecholamine excretion as related to cognitive and emotional reaction patterns.

Authors:  M Frankenhaeuser; I Mellis; A Rissler; C Björkvall; P Pátkai
Journal:  Psychosom Med       Date:  1968 Jan-Feb       Impact factor: 4.312

Review 4.  Adrenergic receptors in man: direct identification, physiologic regulation, and clinical alterations.

Authors:  H J Motulsky; P A Insel
Journal:  N Engl J Med       Date:  1982-07-01       Impact factor: 91.245

5.  Acute regulation of beta adrenergic catecholamine sensitivity in human lymphocytes.

Authors:  J F Krall; M Connelly; M L Tuck
Journal:  J Pharmacol Exp Ther       Date:  1980-09       Impact factor: 4.030

6.  Characterization of alpha 2-adrenergic receptors on human platelets using [3H]yohimbine.

Authors:  H J Motulsky; S J Shattil; P A Insel
Journal:  Biochem Biophys Res Commun       Date:  1980-12-31       Impact factor: 3.575

7.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

8.  Increased numbers of alpha receptors in sympathetic denervation supersensitivity in man.

Authors:  B Davies; D Sudera; G Sagnella; E Marchesi-Saviotti; C Mathias; R Bannister; P Sever
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

9.  beta-Receptor numbers and thermodynamics in denervation supersensitivity.

Authors:  R Bannister; A W Boylston; I B Davies; C J Mathias; P S Sever; D Sudera
Journal:  J Physiol       Date:  1981       Impact factor: 5.182

10.  Biphasic adrenergic modulation of beta-adrenergic receptors in man. Agonist-induced early increment and late decrement in beta-adrenergic receptor number.

Authors:  J F Tohmeh; P E Cryer
Journal:  J Clin Invest       Date:  1980-04       Impact factor: 14.808

View more
  2 in total

1.  Up-regulation of beta-adrenoceptors on circulating mononuclear cells after reduction of central sympathetic outflow by clonidine in normal subjects.

Authors:  Y Zoukos; T Thomaides; D V Pavitt; J P Leonard; M L Cuzner; C J Mathias
Journal:  Clin Auton Res       Date:  1992-06       Impact factor: 4.435

2.  Blockade of Rostral Ventrolateral Medulla Apelin Receptors Does Not Attenuate Arterial Pressure in SHR and L-NAME-Induced Hypertensive Rats.

Authors:  Philip R Griffiths; Stephen J Lolait; Louise E Pearce; Fiona D McBryde; Julian F R Paton; Anne-Marie O'Carroll
Journal:  Front Physiol       Date:  2018-10-24       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.